| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.44B | 8.22B | 7.88B | 6.61B | 7.20B |
| Gross Profit | 1.46B | 2.36B | 2.20B | 1.36B | 1.84B |
| EBITDA | 1.71B | 1.44B | 1.63B | 1.60B | 1.28B |
| Net Income | 398.02M | 187.28M | 401.66M | 549.05M | 245.04M |
Balance Sheet | |||||
| Total Assets | 23.46B | 23.91B | 24.19B | 21.15B | 19.95B |
| Cash, Cash Equivalents and Short-Term Investments | 1.87B | 2.04B | 2.12B | 2.46B | 1.57B |
| Total Debt | 3.38B | 4.22B | 4.65B | 4.97B | 3.14B |
| Total Liabilities | 6.29B | 7.20B | 7.78B | 7.77B | 6.27B |
| Stockholders Equity | 17.17B | 16.71B | 16.41B | 13.38B | 13.68B |
Cash Flow | |||||
| Free Cash Flow | 1.15B | 625.44M | 248.81M | -230.75M | -152.23M |
| Operating Cash Flow | 1.68B | 1.52B | 1.37B | 849.62M | 1.32B |
| Investing Cash Flow | -763.65M | -824.66M | -1.71B | -2.04B | -1.58B |
| Financing Cash Flow | -1.02B | -544.10M | -512.65M | 1.72B | -48.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$22.68B | 9.75 | 5.09% | 3.48% | ― | ― | |
71 Outperform | HK$1.14B | 4.31 | 8.94% | 1.38% | 15.60% | 469.61% | |
70 Outperform | HK$5.58B | 13.83 | 1.61% | 7.48% | 2.77% | 104.40% | |
66 Neutral | HK$214.63B | 13.19 | 6.97% | 4.35% | -7.58% | -6.97% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | HK$116.92M | -33.99 | 2.17% | 8.79% | 6.83% | -91.46% |